S 334 109th Congress Senate Health Accreditation (Medical care) Administrative fees Administrative procedure Administrative remedies Australia Business records Canada Civil Rights and Liberties, Minority Issues Civil actions and liability Commerce Congress Congressional reporting requirements Consumer education Contracts Crime and Law Enforcement Customs administration Damages Defective products Department of Health and Human Services

Pharmaceutical Market Access and Drug Safety Act of 2005

Introduced: February 9, 2005 See on congress.gov

Everywhere this bill has been 6 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Apr 19, 2005

Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 109-143.

Feb 10, 2005

Sponsor introductory remarks on measure. (CR S1253-1254)

Feb 9, 2005

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Feb 9, 2005

Sponsor introductory remarks on measure. (CR S1206)

Feb 9, 2005

Introduced in Senate

Jan 26, 2005

Sponsor introductory remarks on measure. (CR S540-541)

Plain-English summary Congressional Research Service

Pharmaceutical Market Access and Drug Safety Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.

Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use.

Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.

Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.

Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.

States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.

Requires the Secretary to educate consumers regarding prescription drug importation.

Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.

What's happening now April 19, 2005

Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 109-143.

Committees of jurisdiction 1